272 related articles for article (PubMed ID: 24260295)
1. Combination of cytokine responses indicative of latent TB and active TB in Malawian adults.
Hur YG; Gorak-Stolinska P; Ben-Smith A; Lalor MK; Chaguluka S; Dacombe R; Doherty TM; Ottenhoff TH; Dockrell HM; Crampin AC
PLoS One; 2013; 8(11):e79742. PubMed ID: 24260295
[TBL] [Abstract][Full Text] [Related]
2. Immune responses to ESAT-6 and CFP-10 by FASCIA and multiplex technology for diagnosis of M. tuberculosis infection; IP-10 is a promising marker.
Borgström E; Andersen P; Atterfelt F; Julander I; Källenius G; Maeurer M; Rosenkrands I; Widfeldt M; Bruchfeld J; Gaines H
PLoS One; 2012; 7(11):e43438. PubMed ID: 23144772
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic performance of a cytokine and IFN-γ-induced chemokine mRNA assay after Mycobacterium tuberculosis-specific antigen stimulation in whole blood from infected individuals.
Kim S; Lee H; Kim H; Kim Y; Cho JE; Jin H; Kim DY; Ha SJ; Kang YA; Cho SN; Lee H
J Mol Diagn; 2015 Jan; 17(1):90-9. PubMed ID: 25528189
[TBL] [Abstract][Full Text] [Related]
4. Potential Role for Mycobacterium tuberculosis Specific IL-2 and IFN-γ Responses in Discriminating between Latent Infection and Active Disease after Long-Term Stimulation.
Sun Q; Wei W; Sha W
PLoS One; 2016; 11(12):e0166501. PubMed ID: 28033330
[TBL] [Abstract][Full Text] [Related]
5. Mycobacteria-Specific Cytokine Responses Detect Tuberculosis Infection and Distinguish Latent from Active Tuberculosis.
Tebruegge M; Dutta B; Donath S; Ritz N; Forbes B; Camacho-Badilla K; Clifford V; Zufferey C; Robins-Browne R; Hanekom W; Graham SM; Connell T; Curtis N
Am J Respir Crit Care Med; 2015 Aug; 192(4):485-99. PubMed ID: 26030187
[TBL] [Abstract][Full Text] [Related]
6. Identification of immunological biomarkers which may differentiate latent tuberculosis from exposure to environmental nontuberculous mycobacteria in children.
Hur YG; Crampin AC; Chisambo C; Kanyika J; Houben R; Ndhlovu R; Mzembe T; Lalor MK; Saul J; Branson K; Stanley C; Ngwira B; French N; Ottenhoff TH; Dockrell HM; Gorak-Stolinska P
Clin Vaccine Immunol; 2014 Feb; 21(2):133-42. PubMed ID: 24285818
[TBL] [Abstract][Full Text] [Related]
7. Measurement of phenotype and absolute number of circulating heparin-binding hemagglutinin, ESAT-6 and CFP-10, and purified protein derivative antigen-specific CD4 T cells can discriminate active from latent tuberculosis infection.
Hutchinson P; Barkham TM; Tang W; Kemeny DM; Chee CB; Wang YT
Clin Vaccine Immunol; 2015 Feb; 22(2):200-12. PubMed ID: 25520147
[TBL] [Abstract][Full Text] [Related]
8. T cells co-producing Mycobacterium tuberculosis-specific type 1 cytokines for the diagnosis of latent tuberculosis.
Nemeth J; Winkler HM; Karlhofer F; Selenko-Gebauer N; Graninger W; Winkler S
Eur Cytokine Netw; 2010 Mar; 21(1):34-9. PubMed ID: 20146988
[TBL] [Abstract][Full Text] [Related]
9. The effect of HIV coinfection, HAART and TB treatment on cytokine/chemokine responses to Mycobacterium tuberculosis (Mtb) antigens in active TB patients and latently Mtb infected individuals.
Kassa D; de Jager W; Gebremichael G; Alemayehu Y; Ran L; Fransen J; Wolday D; Messele T; Tegbaru B; Ottenhoff TH; van Baarle D
Tuberculosis (Edinb); 2016 Jan; 96():131-40. PubMed ID: 26631832
[TBL] [Abstract][Full Text] [Related]
10. Production of TNF-alpha, IL-12(p40) and IL-17 can discriminate between active TB disease and latent infection in a West African cohort.
Sutherland JS; de Jong BC; Jeffries DJ; Adetifa IM; Ota MO
PLoS One; 2010 Aug; 5(8):e12365. PubMed ID: 20811496
[TBL] [Abstract][Full Text] [Related]
11. Molecular signatures distinguishing active from latent tuberculosis in peripheral blood mononuclear cells, after in vitro antigenic stimulation with purified protein derivative of tuberculin (PPD) or Candida: a preliminary report.
Stern JN; Keskin DB; Romero V; Zuniga J; Encinales L; Li C; Awad C; Yunis EJ
Immunol Res; 2009; 45(1):1-12. PubMed ID: 18648750
[TBL] [Abstract][Full Text] [Related]
12. Ethnicity-tailored novel set of ESAT-6 peptides for differentiating active and latent tuberculosis.
Singh SB; Biswas D; Rawat J; Sindhwani G; Patras A; Devrani S; Sarkar P; Mitra S; Gupta SK
Tuberculosis (Edinb); 2013 Nov; 93(6):618-24. PubMed ID: 24011630
[TBL] [Abstract][Full Text] [Related]
13. Circulating mycobacterial-reactive CD4+ T cells with an immunosuppressive phenotype are higher in active tuberculosis than latent tuberculosis infection.
Kim K; Perera R; Tan DB; Fernandez S; Seddiki N; Waring J; French MA
Tuberculosis (Edinb); 2014 Sep; 94(5):494-501. PubMed ID: 25095750
[TBL] [Abstract][Full Text] [Related]
14. Use of QuantiFERON®-TB Gold in-tube culture supernatants for measurement of antibody responses.
Kimuda SG; Andia-Biraro I; Egesa M; Bagaya BS; Raynes JG; Levin J; Elliott AM; Cose S
PLoS One; 2017; 12(11):e0188396. PubMed ID: 29161328
[TBL] [Abstract][Full Text] [Related]
15. Enhanced IFN-γ, but not IL-2, response to Mycobacterium tuberculosis antigens in HIV/latent TB co-infected patients on long-term HAART.
Desalegn G; Tsegaye A; Gebreegziabiher D; Aseffa A; Howe R
BMC Immunol; 2019 Oct; 20(1):35. PubMed ID: 31601184
[TBL] [Abstract][Full Text] [Related]
16. Identification of mycobacterial bacterioferritin B for immune screening of tuberculosis and latent tuberculosis infection.
Yang X; Wu JB; Liu Y; Xiong Y; Ji P; Wang SJ; Chen Y; Zhao GP; Lu SH; Wang Y
Tuberculosis (Edinb); 2017 Dec; 107():119-125. PubMed ID: 29050758
[TBL] [Abstract][Full Text] [Related]
17. New tools for detecting latent tuberculosis infection: evaluation of RD1-specific long-term response.
Butera O; Chiacchio T; Carrara S; Casetti R; Vanini V; Meraviglia S; Guggino G; Dieli F; Vecchi M; Lauria FN; Marruchella A; Laurenti P; Singh M; Caccamo N; Girardi E; Goletti D
BMC Infect Dis; 2009 Nov; 9():182. PubMed ID: 19930588
[TBL] [Abstract][Full Text] [Related]
18. TNF-α/IL-2 ratio discriminates latent from active tuberculosis in immunocompetent children: a pilot study.
Gourgouillon N; de Lauzanne A; Cottart CH; Curis E; Debord C; Guérin-El Khourouj V; Pédron B; Faye A; Sterkers G
Pediatr Res; 2012 Oct; 72(4):370-4. PubMed ID: 22797138
[TBL] [Abstract][Full Text] [Related]
19. Adjunctive biomarkers for improving diagnosis of tuberculosis and monitoring therapeutic effects.
Hur YG; Kang YA; Jang SH; Hong JY; Kim A; Lee SA; Kim Y; Cho SN
J Infect; 2015 Apr; 70(4):346-55. PubMed ID: 25452040
[TBL] [Abstract][Full Text] [Related]
20. Use of resuscitation promoting factors to screen for tuberculosis infection in household-exposed children in The Gambia.
van Loon W; Gomez MP; Jobe D; Franken KLMC; Ottenhoff THM; Coninx M; Kestens L; Sutherland JS; Kampmann B; Tientcheu LD
BMC Infect Dis; 2020 Jul; 20(1):469. PubMed ID: 32615981
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
